(2026). The use of botulinum toxin type A in the treatment of chronic drug-resistant pain in a patient with type 1 neurofibromatosis. Neurology, Neuropsychiatry, Psychosomatics.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"The Use of Botulinum Toxin Type A in the Treatment of Chronic Drug-resistant Pain in a Patient with Type 1 Neurofibromatosis."
Neurology, Neuropsychiatry, Psychosomatics 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"The Use of Botulinum Toxin Type A in the Treatment of Chronic Drug-resistant Pain in a Patient with Type 1 Neurofibromatosis."
Neurology, Neuropsychiatry, Psychosomatics, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.